DK175621B1 - Præparater med forbedret penetration - Google Patents

Præparater med forbedret penetration Download PDF

Info

Publication number
DK175621B1
DK175621B1 DK198901096A DK109689A DK175621B1 DK 175621 B1 DK175621 B1 DK 175621B1 DK 198901096 A DK198901096 A DK 198901096A DK 109689 A DK109689 A DK 109689A DK 175621 B1 DK175621 B1 DK 175621B1
Authority
DK
Denmark
Prior art keywords
miglyol
diphenhydramine
drug
solvent
weight
Prior art date
Application number
DK198901096A
Other languages
Danish (da)
English (en)
Other versions
DK109689A (da
DK109689D0 (da
Inventor
Majid Mahjour
Bernadette Mauser
Zahra A Rashidbaigi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175621(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK109689D0 publication Critical patent/DK109689D0/da
Publication of DK109689A publication Critical patent/DK109689A/da
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Application granted granted Critical
Publication of DK175621B1 publication Critical patent/DK175621B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Laminated Bodies (AREA)
DK198901096A 1988-03-08 1989-03-07 Præparater med forbedret penetration DK175621B1 (da)

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
US16532288 1988-03-08
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
NZ23692191 1991-01-28
ZA9100624 1991-01-28
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
CA2035143 1991-01-29
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591 1991-01-29
AU7006191 1991-01-29
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
FI910455 1991-01-30
KR910001750 1991-02-01
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
NO910403 1991-02-01
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
JP3892191 1991-02-12
PT9677991 1991-02-15
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen
EP91102354 1991-02-19

Publications (3)

Publication Number Publication Date
DK109689D0 DK109689D0 (da) 1989-03-07
DK109689A DK109689A (da) 1989-09-09
DK175621B1 true DK175621B1 (da) 2004-12-27

Family

ID=32512850

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198901096A DK175621B1 (da) 1988-03-08 1989-03-07 Præparater med forbedret penetration
DK91102354.7T DK0499662T3 (da) 1988-03-08 1991-02-19 Præparater med forøget penetration

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91102354.7T DK0499662T3 (da) 1988-03-08 1991-02-19 Præparater med forøget penetration

Country Status (16)

Country Link
EP (2) EP0332147B1 (de)
JP (2) JP2939264B2 (de)
KR (1) KR100191456B1 (de)
AT (2) ATE90571T1 (de)
AU (2) AU611771B2 (de)
CA (1) CA2035143A1 (de)
DE (2) DE68907081T2 (de)
DK (2) DK175621B1 (de)
ES (2) ES2056981T3 (de)
FI (1) FI910455A (de)
GR (1) GR3014988T3 (de)
IE (2) IE62871B1 (de)
NO (1) NO910403L (de)
NZ (2) NZ228094A (de)
PH (1) PH26548A (de)
PT (1) PT96779B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
EP0793963A4 (de) * 1994-10-24 2001-12-12 Nikken Chemicals Co Ltd Transdermal verabreichbare zubereitung
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
CA2354765A1 (en) * 1998-12-11 2000-06-22 Bakulesh Mafatlal Khamar The process for manufacturing formulation of topical beta blockers with improved efficacy
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
EP3456329A1 (de) 2005-10-12 2019-03-20 Unimed Pharmaceuticals, LLC Verbessertes testosterongel und verfahren zur verwendung
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153295B (it) * 1981-10-23 1987-01-14 Oreal Composizione anidra stabile all'ossidazione e base di antralina o suoi derivati e suo uso nel trattamento delle malattie della pelle
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
DE68907081D1 (de) 1993-07-22
AU634015B2 (en) 1993-02-11
IE910305A1 (en) 1992-07-29
FI910455A (fi) 1992-07-31
JPH04338325A (ja) 1992-11-25
EP0499662B1 (de) 1994-11-30
JPH01272519A (ja) 1989-10-31
KR920016085A (ko) 1992-09-24
DE68907081T2 (de) 1993-10-21
CA2035143A1 (en) 1992-07-30
AU3025889A (en) 1989-09-14
DK109689A (da) 1989-09-09
EP0499662A1 (de) 1992-08-26
AU611771B2 (en) 1991-06-20
EP0332147A3 (en) 1990-09-19
PT96779B (pt) 1998-09-30
GR3014988T3 (en) 1995-05-31
FI910455A0 (fi) 1991-01-30
DE69105480D1 (de) 1995-01-12
DK0499662T3 (da) 1995-05-15
IE62871B1 (en) 1995-03-08
AU7006191A (en) 1992-08-20
JP2939264B2 (ja) 1999-08-25
NO910403L (no) 1992-08-03
DK109689D0 (da) 1989-03-07
IE890390L (en) 1989-09-08
ES2064780T3 (es) 1995-02-01
NZ236921A (en) 1993-08-26
KR100191456B1 (ko) 1999-06-15
ES2056981T3 (es) 1994-10-16
ATE114481T1 (de) 1994-12-15
EP0332147A2 (de) 1989-09-13
NZ228094A (en) 1991-09-25
PT96779A (pt) 1992-08-31
IE64308B1 (en) 1995-07-26
NO910403D0 (no) 1991-02-01
PH26548A (en) 1992-08-19
ATE90571T1 (de) 1993-07-15
EP0332147B1 (de) 1993-06-16
DE69105480T2 (de) 1995-04-06

Similar Documents

Publication Publication Date Title
DK175621B1 (da) Præparater med forbedret penetration
US5019395A (en) Compositions with enhanced penetration
EP0946147B1 (de) Zusammensetzung geeignet zur behandlung der pferdelahmheit
US5869529A (en) Topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
EP0261429B1 (de) Systeme zur Verbesserung der Durchdringungsfähigkeit und deren Zubereitung
KR20070008690A (ko) 항콜린제를 위한 침투 강화 조성물
US20040202705A1 (en) Transdermal administration of huperzine
US20050181031A1 (en) Solifenacin transdermal preparation and method for enhancing transdermal permeation thereof
JP2012507511A (ja) 少なくとも２種の透過増強剤を組み合わせて含む局所用組成物
JP4549006B2 (ja) ゲル軟膏
JP5052558B2 (ja) ゲル軟膏
US4931283A (en) Menthol enhancement of transdermal drug delivery
JP3487633B2 (ja) 皮膚疾患治療乳剤
EP0147146A2 (de) Erhöhung der transdermalen Wirkstoffaufnahme
EP0535237A1 (de) Zusammensetzung zur linderung von hautirritationen sowie diese enthaltende externa zur transdermalen verabreichung
US20080260842A1 (en) Permeation enhancing compositions for anticholinergic agents
KR20070059079A (ko) 경피 페로스피론 투여용 의약적 조성물
KR0145678B1 (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
US5869088A (en) Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline
JPS62223119A (ja) 外用クリ−ム製剤
WO1999007355A1 (fr) Preparation contenant de l'idebenone pour administration par voie percutanee
JPS61204117A (ja) 経皮吸収外用剤
EP0787490A1 (de) Topische Zusammensetzung zur Prevention und Behandlung der mit Herpesvirus assoziierten Verletzungen und Wunde
JP2001019640A (ja) 外用組成物
JP2016216384A (ja) 経皮吸収型製剤

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK